Tetrandrine, an Effective Inhibitor of COVID-19 Main Protease (Mpro); Insights from Molecular Docking and Dynamics Simulations.

AB SK, S Begum, P Bandari… - International Journal of …, 2023 - search.ebscohost.com
Background: Natural products emerged as potential lead molecules in the drug discovery
paradigm. During COVID-19 pandemic, researchers explored several natural agents with …

[HTML][HTML] Synthetic and Herbal Drugs Registered in Clinical Trials on COVID-19: a Review on Recent Research

M Mehrabi, S Sajadimajd… - Journal of Genetic …, 2023 - journals.umz.ac.ir
COVID-19 emerged as a widespread worldwide ailment in 2019, with a continued
breakdown of novel gamma and lambda variants. Given the high incidence of COVID-19 …

Abordaje de la Terapia Física Comunitaria en adultos mayores post Covid-19

MA Antunez, JLA Mora, VBG Curbelo - Revista Científica Cultura …, 2022 - rccd.ucf.edu.cu
La evaluación de parámetros para proyectar estrategias de recuperación, después de la
Covid-19, sustenta el objetivo de este trabajo es valorar la disnea y la fatiga durante el test …

COVID-19 ile ilgili Türkiye'deki girişimsel çalışmaların incelenmesi: sistematik bir derleme

E Ünal, AA Dönmez, Fİ Çınar - Hacettepe Üniversitesi Hemşirelik …, 2023 - dergipark.org.tr
Amaç: Bu çalışmada, COVID-19'un tedavisi ve yönetimi için yürütülmüş ulusal ve
uluslararası veri tabanlarında yayınlanmış Türkiye adresli girişimsel araştırmaların sistematik …

[HTML][HTML] Prognosis of Covid-19 on its 1st Anniversary: Global V/s Indian Scenario

SM Biradar, B Kohima, MS Mulimani… - Biomedical and …, 2024 - biomedpharmajournal.org
Abstract Corona virus disease 2019 (Covid-19) is an acute respiratory illness caused by the
Corona virus. Corona virus 2 (SARS-CoV-2) is a continuing global health crisis that has …

Harnessing the Natural Toxic Metabolites in COVID‐19

A Bahrami, M Taheri, MR Arabestani… - Evidence‐Based …, 2022 - Wiley Online Library
SARS‐CoV‐2 is a novel coronavirus and the cause of the recent pandemic; it is an
enveloped β‐coronavirus. SARS‐CoV‐2 appear in the Wuhan City of China for the first time …

COVID-19 associated mucormycosis (CAM) and other fungal infections: A review

CT Swamy - Microbes and Infectious Diseases, 2024 - mid.journals.ekb.eg
Background: SARS-CoV-2 virus caused the COVID-19 epidemic, which eventually turned
into a global pandemic. Immunomodulatory drugs used in COVID-19 treatment pave the way …

[PDF][PDF] Diverse effects of clarithromycin and proposal of its clinical application for treating COVID-19 as a repurposing drug

N Takemori, HK Ooi, G Imai, M Saio - Tropical Biomedicine, 2021 - msptm.org
Outbreak of SARS-CoV-2 has been declared a pandemic, which is a serious threat to
human health. The disease was named coronavirus disease 2019 (COVID-19). Until now …

[PDF][PDF] Novel Insight into the Cellular and Molecular Signaling Pathways of Costus speciosus in the Treatment of COVID-19: A Review

D Lodh, A Chakraborty - 2024 - cellnatsci.com
The latest pandemic of coronavirus disease 2019 (COVID-19), caused by the infection of
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has brought upon the …

Doxycycline is a safe alternative to Hydroxychloroquine+ Azithromycin to prevent clinical worsening and hospitalization in mild COVID-19 patients: An open label …

E Sobngwi, S Zemsi, M Guewo-Fokeng, JC Katte… - medRxiv, 2021 - medrxiv.org
Objective We aimed to compare the safety and efficacy of a doxycycline-based regimen
against the national standard guidelines (Hydroxychloroquine plus Azithromycin) for the …